Insider Trading activities of Relypsa Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Relypsa Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Relypsa Inc since year 2005. Table 2 shows the detailed insider transactions of Relypsa Inc since 2005. The reporting company's ticker symbol is RLYP. The reporting company's CIK number is 1416792.
The total value of stock buying since 2005 is $38,845,902.
The total value of stock sales since 2005 is $283,905,589.
The total value of stock option exercises since 2005 is $7,328,677.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Relypsa Inc (RLYP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-08 500 $15,960 37,510 $1,198,799 0 $0
2016-07 0 $0 4,043,600 $129,388,328 0 $0
2016-06 0 $0 6,078 $117,426 0 $0
2016-03 37,000 $486,870 0 $0 0 $0
2015-12 0 $0 605,750 $16,624,254 100,750 $607,960
2015-10 500,000 $6,222,500 0 $0 0 $0
2015-09 0 $0 646 $14,832 0 $0
2015-08 0 $0 8,508 $211,014 0 $0
2015-07 0 $0 30,000 $1,015,090 25,000 $185,000
2015-06 0 $0 18,329 $658,283 8,555 $63,307
2015-05 0 $0 1,483,385 $50,690,340 25,834 $171,102
2015-04 0 $0 5,832 $206,178 5,832 $23,094
2015-03 0 $0 19,353 $768,731 18,834 $79,195
2015-02 0 $0 31,182 $1,173,831 10,834 $52,663
2015-01 0 $0 73,834 $2,566,329 73,834 $271,857
2014-12 0 $0 611,806 $18,408,470 22,169 $103,084
2014-11 0 $0 40,834 $1,000,160 40,834 $188,668
2014-10 0 $0 2,500 $48,970 2,500 $11,625
2014-09 0 $0 715,707 $18,537,670 9,167 $44,911
2014-08 0 $0 1,522,252 $40,096,016 99,252 $451,258
2014-07 0 $0 49,167 $1,180,868 49,167 $197,576
2013-11 2,920,052 $32,120,572 0 $0 5,602,650 $4,877,377

Table 2. Detailed insider stock purchases, sales, and option exercises of Relypsa Inc insiders (RLYP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-08-17 Dondero James D (10% Owner) Buy 500 31.92 15,960
2016-08-16 Montgomery Monte (Chief Accounting Officer) Sale 510 31.92 16,279
2016-08-11 Dondero James D (10% Owner) Sale 37,000 31.96 1,182,520
2016-07-25 Isaly Samuel D Sale 343,600 31.98 10,988,328
2016-07-22 Isaly Samuel D Sale 3,700,000 32.00 118,400,000
2016-06-07 Hillan Kenneth J. Sale 1,013 19.31 19,563
2016-06-07 Butler John P. Sale 1,013 19.32 19,570
2016-06-07 Torley Helen Sale 1,013 19.32 19,570
2016-06-07 Hastings Paul J Sale 1,013 19.32 19,573
2016-06-07 Spiegelman Daniel K Sale 1,013 19.31 19,562
2016-06-07 Mcgirr David W J Sale 1,013 19.34 19,588
2016-03-16 Ball Kristine M (Chief Financial Officer & SVP) Buy 7,000 12.15 85,050
2016-03-15 Schuetz Thomas J. Buy 30,000 13.39 401,820
2015-12-31 Stahl Wilhelm (SVP, Chief Technology Officer) Sale 20,000 28.53 570,560
2015-12-31 Stahl Wilhelm (SVP, Chief Technology Officer) Option Ex 20,000 3.96 79,200
2015-12-23 Isaly Samuel D Sale 100,000 27.16 2,716,000
2015-12-22 Isaly Samuel D Sale 150,000 26.70 4,005,749
2015-12-21 Isaly Samuel D Sale 250,000 27.95 6,986,250
2015-12-09 Berman Lance (Chief Medical Officer and SVP) Sale 750 29.50 22,125
2015-12-09 Berman Lance (Chief Medical Officer and SVP) Option Ex 750 7.40 5,550
2015-12-07 Orwin John A (President & CEO) Sale 15,000 28.68 430,170
2015-12-07 Orwin John A (President & CEO) Option Ex 10,000 7.40 74,000
2015-12-07 Berman Lance (Chief Medical Officer and SVP) Sale 30,000 29.78 893,400
2015-12-07 Berman Lance (Chief Medical Officer and SVP) Option Ex 30,000 5.11 153,210
2015-12-04 Orwin John A (President & CEO) Sale 20,000 25.00 500,000
2015-12-04 Orwin John A (President & CEO) Option Ex 20,000 7.40 148,000
2015-12-02 Orwin John A (President & CEO) Sale 20,000 25.00 500,000
2015-12-02 Orwin John A (President & CEO) Option Ex 20,000 7.40 148,000
2015-10-22 Isaly Samuel D Buy 500,000 12.45 6,222,500
2015-09-02 Ball Kristine M (Chief Financial Officer & SVP) Sale 646 22.96 14,832
2015-08-17 Corbett Mary (Senior VP, Human Resources) Sale 522 24.72 12,904
2015-08-17 Krasnow Ronald A. (See Remarks) Sale 522 24.75 12,922
2015-08-17 Stahl Wilhelm (SVP, Chief Technology Officer) Sale 522 24.70 12,893
2015-08-17 Lockey Claire (See Remarks) Sale 522 24.69 12,888
2015-08-17 Orwin John A (President & CEO) Sale 5,000 24.84 124,225
2015-08-17 Berman Lance (Chief Medical Officer and SVP) Sale 710 24.77 17,585
2015-08-17 Ball Kristine M (Chief Financial Officer & SVP) Sale 710 24.79 17,597
2015-07-31 Orwin John A (President & CEO) Sale 10,000 33.83 338,250
2015-07-31 Orwin John A (President & CEO) Option Ex 5,000 7.40 37,000
2015-07-30 Orwin John A (President & CEO) Sale 20,000 33.84 676,840
2015-07-30 Orwin John A (President & CEO) Option Ex 20,000 7.40 148,000
2015-06-11 Butler John P. Sale 1,100 34.62 38,086
2015-06-11 Schuetz Thomas J. Sale 1,000 34.57 34,571
2015-06-11 Hastings Paul J Sale 1,454 34.63 50,359
2015-06-11 Mcgirr David W J Sale 1,220 34.67 42,299
2015-06-01 Orwin John A (President & CEO) Sale 13,555 36.37 492,968
2015-06-01 Orwin John A (President & CEO) Option Ex 8,555 7.40 63,307
2015-05-29 Orwin John A (President & CEO) Sale 20,000 36.69 733,740
2015-05-29 Orwin John A (President & CEO) Option Ex 20,000 7.40 148,000
2015-05-18 Isaly Samuel D Sale 1,457,551 34.13 49,746,215
2015-05-11 Veitinger Klaus R Dr Sale 5,834 36.06 210,385
2015-05-11 Veitinger Klaus R Dr Option Ex 5,834 3.96 23,102
2015-04-10 Veitinger Klaus R Dr Sale 5,832 35.35 206,178
2015-04-10 Veitinger Klaus R Dr Option Ex 5,832 3.96 23,094
2015-03-10 Veitinger Klaus R Dr Sale 5,834 38.67 225,594
2015-03-10 Veitinger Klaus R Dr Option Ex 5,834 4.30 25,115
2015-03-05 Ball Kristine M (Chief Financial Officer & SVP) Sale 3,000 41.00 123,000
2015-03-05 Ball Kristine M (Chief Financial Officer & SVP) Option Ex 3,000 3.96 11,880
2015-03-04 Lockey Claire (See Remarks) Sale 10,000 40.00 400,000
2015-03-04 Lockey Claire (See Remarks) Option Ex 10,000 4.22 42,200
2015-03-03 Ball Kristine M (Chief Financial Officer & SVP) Sale 519 38.80 20,137
2015-02-27 Krasnow Ronald A. (See Remarks) Sale 348 39.00 13,572
2015-02-26 Krasnow Ronald A. (See Remarks) Sale 5,000 39.00 195,000
2015-02-25 Krasnow Ronald A. (See Remarks) Sale 5,000 39.00 195,000
2015-02-24 Krasnow Ronald A. (See Remarks) Sale 5,000 39.00 195,000
2015-02-24 Berman Lance (Chief Medical Officer and SVP) Sale 5,000 38.22 191,110
2015-02-24 Berman Lance (Chief Medical Officer and SVP) Option Ex 5,000 5.11 25,535
2015-02-23 Krasnow Ronald A. (See Remarks) Sale 5,000 39.00 195,000
2015-02-10 Veitinger Klaus R Dr Sale 5,834 32.42 189,149
2015-02-10 Veitinger Klaus R Dr Option Ex 5,834 4.65 27,128
2015-01-21 Krasnow Ronald A. (See Remarks) Sale 55,000 35.00 1,925,000
2015-01-21 Krasnow Ronald A. (See Remarks) Option Ex 55,000 3.56 195,800
2015-01-21 Lockey Claire (See Remarks) Sale 5,000 35.00 175,000
2015-01-21 Lockey Claire (See Remarks) Option Ex 5,000 4.65 23,250
2015-01-21 Ball Kristine M (Chief Financial Officer & SVP) Sale 3,000 36.00 108,000
2015-01-21 Ball Kristine M (Chief Financial Officer & SVP) Option Ex 3,000 3.96 11,880
2015-01-14 Krasnow Ronald A. (See Remarks) Sale 5,000 33.77 168,830
2015-01-14 Krasnow Ronald A. (See Remarks) Option Ex 5,000 2.76 13,799
2015-01-12 Veitinger Klaus R Dr Sale 5,834 32.48 189,499
2015-01-12 Veitinger Klaus R Dr Option Ex 5,834 4.65 27,128
2014-12-12 Veitinger Klaus R Dr Sale 9,852 32.50 320,190
2014-12-12 Veitinger Klaus R Dr Option Ex 9,852 4.65 45,811
2014-12-11 Veitinger Klaus R Dr Sale 150 32.50 4,875
2014-12-11 Veitinger Klaus R Dr Option Ex 150 4.65 697
2014-12-10 Veitinger Klaus R Dr Sale 4,167 31.37 130,710
2014-12-10 Veitinger Klaus R Dr Option Ex 4,167 4.65 19,376
2014-12-09 Lockey Claire (See Remarks) Sale 8,000 30.00 240,000
2014-12-09 Lockey Claire (See Remarks) Option Ex 8,000 4.65 37,200
2014-12-09 5am Co-investors Iii, L.p. Sale 589,637 30.04 17,712,695
2014-11-28 Berman Lance (Chief Medical Officer and SVP) Sale 5,000 25.00 125,000
2014-11-28 Berman Lance (Chief Medical Officer and SVP) Option Ex 5,000 5.11 25,535
2014-11-25 Berman Lance (Chief Medical Officer and SVP) Sale 15,000 25.00 375,000
2014-11-25 Berman Lance (Chief Medical Officer and SVP) Option Ex 15,000 5.11 76,605
2014-11-24 Berman Lance (Chief Medical Officer and SVP) Sale 15,000 25.00 375,000
2014-11-24 Berman Lance (Chief Medical Officer and SVP) Option Ex 15,000 3.96 59,400
2014-11-20 Veitinger Klaus R Dr Sale 3,334 22.50 75,015
2014-11-20 Veitinger Klaus R Dr Option Ex 3,334 4.65 15,503
2014-11-10 Veitinger Klaus R Dr Sale 2,500 20.06 50,145
2014-11-10 Veitinger Klaus R Dr Option Ex 2,500 4.65 11,625
2014-10-10 Veitinger Klaus R Dr Sale 2,500 19.59 48,970
2014-10-10 Veitinger Klaus R Dr Option Ex 2,500 4.65 11,625
2014-09-24 Berman Lance (Chief Medical Officer and SVP) Sale 5,000 22.00 110,000
2014-09-24 Berman Lance (Chief Medical Officer and SVP) Option Ex 5,000 5.11 25,535
2014-09-17 Isaly Samuel D Sale 49,000 25.07 1,228,430
2014-09-16 5am Co-investors Ii Lp Sale 612,540 26.03 15,944,416
2014-09-16 Isaly Samuel D Sale 45,000 25.75 1,158,975
2014-09-10 Veitinger Klaus R Dr Sale 4,167 23.00 95,849
2014-09-10 Veitinger Klaus R Dr Option Ex 4,167 4.65 19,376
2014-08-29 Stahl Wilhelm (SVP, Pharmaceutical Operations) Sale 15,785 25.29 399,250
2014-08-29 Stahl Wilhelm (SVP, Pharmaceutical Operations) Option Ex 15,785 4.30 67,954
2014-08-26 5am Co-investors Ii Lp Sale 96,310 26.53 2,555,104
2014-08-25 Berman Lance (Chief Medical Officer and SVP) Sale 5,000 26.48 132,380
2014-08-25 Berman Lance (Chief Medical Officer and SVP) Option Ex 5,000 7.40 37,000
2014-08-25 5am Co-investors Ii Lp Sale 336,690 26.50 8,922,285
2014-08-22 Berman Lance (Chief Medical Officer and SVP) Sale 15,000 25.69 385,350
2014-08-22 Berman Lance (Chief Medical Officer and SVP) Option Ex 15,000 5.68 85,200
2014-08-15 Isaly Samuel D Sale 990,000 26.35 26,086,500
2014-08-11 Veitinger Klaus R Dr Sale 4,167 27.73 115,563
2014-08-11 Veitinger Klaus R Dr Option Ex 4,167 4.65 19,376
2014-08-08 Stahl Wilhelm (SVP, Pharmaceutical Operations) Sale 49,300 25.09 1,237,084
2014-08-08 Stahl Wilhelm (SVP, Pharmaceutical Operations) Option Ex 49,300 3.96 195,228
2014-08-08 Lockey Claire (See Remarks) Sale 10,000 26.25 262,500
2014-08-08 Lockey Claire (See Remarks) Option Ex 10,000 4.65 46,500
2014-07-24 Berman Lance (Chief Medical Officer and SVP) Sale 15,000 24.18 362,745
2014-07-24 Berman Lance (Chief Medical Officer and SVP) Option Ex 15,000 3.96 59,400
2014-07-23 Berman Lance (Chief Medical Officer and SVP) Sale 15,000 24.45 366,780
2014-07-23 Berman Lance (Chief Medical Officer and SVP) Option Ex 15,000 3.96 59,400
2014-07-22 Berman Lance (Chief Medical Officer and SVP) Sale 15,000 23.67 354,990
2014-07-22 Berman Lance (Chief Medical Officer and SVP) Option Ex 15,000 3.96 59,400
2014-07-10 Veitinger Klaus R Dr Sale 4,167 23.12 96,353
2014-07-10 Veitinger Klaus R Dr Option Ex 4,167 4.65 19,376
2013-11-20 Ratcliffe Liam (Other) Buy 185,978 11.00 2,045,758
2013-11-20 Ratcliffe Liam (Other) Option Ex 25,977 9.19 238,598
2013-11-20 5am Co-investors Iii, L.p. (10% Owner) Buy 372,692 11.00 4,099,612
2013-11-20 5am Co-investors Iii, L.p. (10% Owner) Option Ex 558,220 .17 94,897
2013-11-20 Orwin John A (President & CEO) Buy 15,000 11.00 165,000
2013-11-20 5am Co-investors Ii Lp (10% Owner) Option Ex 133,546 3.17 424,008
2013-11-20 Hunt Ronald (Director) Buy 185,978 11.00 2,045,758
2013-11-20 Hunt Ronald (Director) Option Ex 25,977 9.19 238,598
2013-11-20 Rocklage Scott M (Director) Buy 372,692 11.00 4,099,612
2013-11-20 Rocklage Scott M (Director) Option Ex 691,766 1.30 1,645,230
2013-11-20 Silverstein Jonathan (Director) Buy 712,192 11.00 7,834,112
2013-11-20 Silverstein Jonathan (Director) Option Ex 1,744,711 .17 296,600
2013-11-20 Isaly Samuel D Buy 712,192 11.00 7,834,112
2013-11-20 Isaly Samuel D Option Ex 1,744,711 .17 296,600

Insider trading activities including stock purchases, stock sales, and option exercises of RLYP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Relypsa Inc (symbol RLYP, CIK number 1416792) see the Securities and Exchange Commission (SEC) website.